These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 9891527)

  • 1. Flow cytometry as a prognostic method for the identification of adenomatous hyperplasia at risk of developing endometrial carcinoma.
    Lindahl B; Willén R
    Anticancer Res; 1998; 18(6B):4611-2. PubMed ID: 9891527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
    Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
    Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid receptor concentrations as a prognostic factor in atypical endometrial hyperplasia.
    Lindahl B; Willén R
    Anticancer Res; 1998; 18(5B):3793-5. PubMed ID: 9854498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A study on DNA content and cell cycle phase analysis in endometrial carcinoma].
    Xue F; Jiao S; Zhao F
    Zhonghua Fu Chan Ke Za Zhi; 1996 Apr; 31(4):216-9. PubMed ID: 8758776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A strong prognostic variable in endometrial carcinoma: flow cytometric S-phase fraction.
    Kaleli S; Kösebay D; Beşe T; Demirkiran F; Oz UA; Arvas M; Aydinli K; Erkün E
    Cancer; 1997 Mar; 79(5):944-51. PubMed ID: 9041157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy and S-phase fraction analyses of hyperplastic, atypical and cancerous endometrium using flow cytometry from paraffin-embedded tissues.
    Pervez S; Hitchcock A; Sinton TM; Mani A; Smith JL
    Pathol Res Pract; 2002; 198(1):13-7. PubMed ID: 11866205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of high-risk groups in endometrial carcinoma stage I-II. A combination of DNA- and steroid receptor-measurements identifies early deaths from the disease.
    Lindahl B; Ranstam J; Norgren A; Willén R
    Anticancer Res; 1995; 15(3):1095-100. PubMed ID: 7645932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of cell kinetics in endometrial adenocarcinoma.
    Mariani L; Conti L; Antenucci A; Vercillo M; Atlante M; Gandolfo GM
    Anticancer Res; 2000; 20(5B):3569-74. PubMed ID: 11131664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous endometrial hyperplasia. A 5 year follow-up of 82 patients after high-dose gestagen treatment.
    Lindahl B; Willén R
    Anticancer Res; 1994; 14(6B):2831-4. PubMed ID: 7872726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endometrial hyperplasia and carcinoma in endometrial polyps: clinicopathologic and follow-up findings.
    Mittal K; Da Costa D
    Int J Gynecol Pathol; 2008 Jan; 27(1):45-8. PubMed ID: 18156974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Outcome analysis of conservative treatment of well-differentiated endometrial adenocarcinoma and severe atypical hyperplasia in young women].
    Yu M; Shen K; Yang JX; Huang HF; Wu M; Pan LY; Lang JH; Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 2006 Apr; 41(4):242-5. PubMed ID: 16759458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flow cytometry (FCM) analysis of endometrial hyperplasia and carcinoma.
    Kysela B; Siracký J; Redecha M; Bárdos A
    Neoplasma; 1990; 37(5):489-95. PubMed ID: 2234210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
    Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
    Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-risk endometrial carcinoma: assessment of a treatment policy based on tumor ploidy and identification of additional prognostic indicators.
    Lim P; Aquino-Parsons CF; Wong F; Dupuis B; Phillips D; Zhou C; Gilks CB
    Gynecol Oncol; 1999 May; 73(2):191-5. PubMed ID: 10329033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Characteristic of cystic glandular hyperplasia as a precursor of endometrial carcinoma].
    Yokosuka K; Teshima H; Yamakawa Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1241-6. PubMed ID: 7844442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flow cytometry in primary breast carcinomas: prognostic impact of S-phase fraction according to different analysis patterns.
    Michels JJ; Marnay J; Plancoulaine B; Chasle J
    Cytometry B Clin Cytom; 2004 May; 59(1):32-9. PubMed ID: 15108168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow cytometric analysis of cell surface antigen recognized by monoclonal antibody (MSN-1) in normal, hyperplasia, and carcinoma of endometrial cells: its diagnostic value for endometrial carcinoma.
    Kobayashi Y; Tsukazaki K; Ohta K; Mikami M; Kubushiro K; Nozawa S
    Cytometry; 1997 Feb; 30(1):23-7. PubMed ID: 9056738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endometrial hyperplasia following estrogen treatment without the addition of gestagen. A follow-up study after withdrawal of estrogens.
    Lindahl B; Willén R
    Anticancer Res; 1991; 11(6):2071-3. PubMed ID: 1776842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.